Full Text View
Tabular View
No Study Results Posted
Related Studies
Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase
This study has been completed.
Study NCT00630747   Information provided by Shire Human Genetic Therapies, Inc.
First Received: February 28, 2008   Last Updated: March 6, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hunter Syndrome
Mucopolysaccharidosis II
Additional conditions recognized in this trial
Mucopolysaccharidoses
Syndrome
More general conditions related to this trial
Carbohydrate Metabolism, Inborn Errors
Connective Tissue Diseases
Disease
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Heredodegenerative Disorders, Nervous System
Lysosomal Storage Diseases
Mental Retardation
Mental Retardation, X-Linked
Metabolic Diseases
Metabolism, Inborn Errors
Mucinoses
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes
Interventions listed in this trial
Idursulfase
Sponsors listed in this trial
Shire Human Genetic Therapies, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services